CAHILL JOHN T 4

What Happened

• John T. Cahill, a director of Colgate-Palmolive Co. (CL), was granted 2,075 ordinary shares and a derivative award covering 2,424 shares on May 11, 2026 as part of the company's annual director compensation.
• Both grants were reported at $0.00 per share (standard for stock awards/options reported on Form 4). The 2,075-share award includes 2,019 shares previously reported as directly owned, so the net new directly held shares from this grant are 56.
• The 2,424-share item is an option grant (derivative). It vests in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date (i.e., ~808 shares vests each year).

Key Details

• Transaction date: May 11, 2026; filing date: May 13, 2026 (timely filing).
• Awarded shares: 2,075 shares @ $0.00 (code A — award/grant).
• Derivative/option grant: 2,424 shares @ $0.00 (code A — option grant); exercisable in three equal annual installments starting ~May 11, 2027.
• Net new direct shares: 56 (2,075 grant minus 2,019 shares previously reported as owned per filing footnote).
• Footnotes: F1 = annual director stock grant under the incentive plan; F3/F4 = annual director option grant, vesting schedule noted.
• No sale or purchase for cash was reported; these are routine, non-cash director compensation awards.

Context

• These are routine annual director compensation awards and do not indicate a market sale or immediate purchase. The option grant vests over time, so any future exercise would be subject to vesting and potential exercise costs; nothing in this filing shows an immediate exercise or sale.
• For retail investors, purchases can be more informative than routine director grants; here the filing documents compensation-related awards rather than an open-market buy or sell.